α2-noradrenergic effects on ERP and behavioral indices of auditory information processing

被引:29
作者
Turetsky, BI
Fein, G
机构
[1] Univ Penn, Dept Psychiat, Div Neuropsychiat, Philadelphia, PA 19104 USA
[2] Neurobehav Res Inc, Corte Madera, CA USA
关键词
norepinephrine; event-related potentials; P300; attention; psychopharmacology; schizophrenia;
D O I
10.1017/S0048577201392041
中图分类号
B84 [心理学];
学科分类号
04 ; 0402 ;
摘要
Norepinephrine is believed to modulate CNS processing of environmental signals. However, its specific role in stimulus evaluation processes has not been delineated. We examined the effects of the alpha2 noradrenergic agents, clonidine and yohimbine, on ERP and performance measures of auditory information processing. Ten healthy participants performed a three-tone target detection experiment, receiving either placebo, 0.2 mg clonidine, or 30 mg yohimbine, in a double-blind randomized design. The principal locus of action of the noradrenergic agents occurred between 100 and 200 ins poststimulus. P200 latency was sped by yohimbine and slowed by clonidine, and the frontal P3a was shifted in tandem. Components related to tat-get detection (N250 and P3b) were unaffected. The results suggest that norepinephrine modulates CNS mechanisms of selective attention to infrequent stimuli. This may be relevant for patients with schizophrenia, a subset of whom exhibit selective abnormalities of these same ERP components. Our results offer a possible link between these two sets of findings, suggesting that some patients with schizophrenia may have dysfunctional noradrenergic systems.
引用
收藏
页码:147 / 157
页数:11
相关论文
共 69 条
[1]   MODULATION OF THE GATING OF AUDITORY EVOKED-POTENTIALS BY NOREPINEPHRINE - PHARMACOLOGICAL EVIDENCE OBTAINED USING A SELECTIVE NEUROTOXIN [J].
ADLER, LE ;
PANG, K ;
GERHARDT, G ;
ROSE, GM .
BIOLOGICAL PSYCHIATRY, 1988, 24 (02) :179-190
[2]   YOHIMBINE IMPAIRS P50 AUDITORY SENSORY GATING IN NORMAL SUBJECTS [J].
ADLER, LE ;
HOFFER, L ;
NAGAMOTO, HT ;
WALDO, MC ;
KISLEY, MA ;
GIFFITH, JM .
NEUROPSYCHOPHARMACOLOGY, 1994, 10 (04) :249-257
[3]   SENSORY PHYSIOLOGY AND CATECHOLAMINES IN SCHIZOPHRENIA AND MANIA [J].
ADLER, LE ;
GERHARDT, GA ;
FRANKS, R ;
BAKER, N ;
NAGAMOTO, H ;
DREBING, C ;
FREEDMAN, R .
PSYCHIATRY RESEARCH, 1990, 31 (03) :297-309
[4]  
ADLER LE, 1982, BIOL PSYCHIAT, V17, P638
[5]  
ASTONJONES G, 1994, J NEUROSCI, V14, P4467
[6]   NEUROPHYSIOLOGICAL ASSESSMENT OF SENSORY GATING IN PSYCHIATRIC-INPATIENTS - COMPARISON BETWEEN SCHIZOPHRENIA AND OTHER DIAGNOSES [J].
BAKER, N ;
ADLER, LE ;
FRANKS, RD ;
WALDO, M ;
BERRY, S ;
NAGAMOTO, H ;
MUCKLE, A ;
FREEDMAN, R .
BIOLOGICAL PSYCHIATRY, 1987, 22 (05) :603-617
[7]  
BRAFF DL, 1990, ARCH GEN PSYCHIAT, V47, P181
[8]   INFORMATION-PROCESSING AND ATTENTION DYSFUNCTIONS IN SCHIZOPHRENIA [J].
BRAFF, DL .
SCHIZOPHRENIA BULLETIN, 1993, 19 (02) :233-259
[9]   EFFECTS OF ORAL SCOPOLAMINE ON HUMAN STIMULUS EVALUATION [J].
CALLAWAY, E ;
HALLIDAY, R ;
NAYLOR, H ;
SCHECHTER, G .
PSYCHOPHARMACOLOGY, 1985, 85 (02) :133-138
[10]  
CALLAWAY E, 1984, BIOL PSYCHIAT, V19, P649